Related references
Note: Only part of the references are listed.Antiphospholipid syndrome: antibodies to Domain 1 of β2-glycoprotein 1 correctly classify patients at risk
V. Pengo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2-Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti-Domain 1 to Anti-Domain 4/5 As a Useful New Biomarker for Antiphospholipid Syndrome
Laura Andreoli et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with 'seronegative' antiphospholipid syndrome
Laura Cousins et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis
Charis Pericleous et al.
RHEUMATOLOGY (2015)
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
Maria Laura Bertolaccini et al.
AUTOIMMUNITY REVIEWS (2014)
A non-complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome
Chiara Agostinis et al.
BLOOD (2014)
Role of antiphospholipid score and anti-β2-glycoprotein I Domain I autoantibodies in the diagnosis of antiphospholipid syndrome
R. Mondejar et al.
CLINICA CHIMICA ACTA (2014)
Summary of the 9th meeting of the European Forum on Antiphospholipid Antibodies
J. Swadzba et al.
LUPUS (2014)
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
Pier Luigi Meroni et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Value of Isolated IgA Anti-β2-Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome
Vijaya Murthy et al.
ARTHRITIS AND RHEUMATISM (2013)
Utility of Antiphosphatidylserine/Prothrombin and IgA Antiphospholipid Assays in Systemic Lupus Erythematosus
Ehtisham Akhter et al.
JOURNAL OF RHEUMATOLOGY (2013)
The Pathogenesis of the Antiphospholipid Syndrome
Bill Giannakopoulos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies
Laura Andreoli et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
International Consensus Guidelines on Anticardiolipin and Anti-beta 2-Glycoprotein I Testing: Report From the 13th International Congress on Antiphospholipid Antibodies
Gabriella Lakos et al.
ARTHRITIS AND RHEUMATISM (2012)
Autoantibodies to domain 1 of beta 2 glycoprotein 1: A promising candidate biomarker for risk management in antiphospholipid syndrome
Michael Mahler et al.
AUTOIMMUNITY REVIEWS (2012)
Current International Initiatives in Antiphospholipid Antibody Testing
Rohan Willis et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile?
Laura Andreoli et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Immune responses against domain I of β2-glycoprotein I are driven by conformational changes: Domain I of β2-glycoprotein I harbors a cryptic immunogenic epitope
Bas de Laat et al.
ARTHRITIS AND RHEUMATISM (2011)
Evaluating the conformation of recombinant domain I of β2-glycoprotein I and its interaction with human monoclonal antibodies
Charis Pericleous et al.
MOLECULAR IMMUNOLOGY (2011)
Antibodies to Domain I of β2Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS)
A. Banzato et al.
THROMBOSIS RESEARCH (2011)
Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
Bas de Laat et al.
CURRENT RHEUMATOLOGY REPORTS (2011)
β2-Glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome
Cetin Agar et al.
BLOOD (2010)
Naturally occurring free thiols within β2-glycoprotein I in vivo: nitrosylation, redox modification by endothelial cells, and regulation of oxidative stress-induced cell injury
Yiannis Ioannou et al.
BLOOD (2010)
IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus
Nadera J. Sweiss et al.
PLOS ONE (2010)
Thrombin Binding Predicts the Effects of Sequence Changes in a Human Monoclonal Antiphospholipid Antibody on Its In Vivo Biologic Actions
Ian Giles et al.
JOURNAL OF IMMUNOLOGY (2009)
In vivo inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of β2-glycoprotein I: proof of concept
Y. Ioannou et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study
B. De Laat et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
A protocol for determination of anticardiolipin antibodies by ELISA
Silvia S. Pierangeli et al.
NATURE PROTOCOLS (2008)
Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I - Mutation studies including residues R39 to R43
Yiannis Ioannou et al.
ARTHRITIS AND RHEUMATISM (2007)
Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of β2-GPI
G. Michael Iverson et al.
JOURNAL OF AUTOIMMUNITY (2006)
Pathogenic anti-β2-glycoprotein I antibodies recognize domain I of β2-glycoprotein I only after a conformational change
B de Laat et al.
BLOOD (2006)
A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli -: art. no. 8
Y Ioannou et al.
BMC BIOTECHNOLOGY (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
IgG antibodies that recognize epitope Gly40-Arg43 in domain I of β2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis
B de Laat et al.
BLOOD (2005)
Relative importance of different human aPL derived heavy and light chains in the binding of aPL to cardiolipin
IP Giles et al.
MOLECULAR IMMUNOLOGY (2003)
Use of single point mutations in domain I of β2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies
GM Iverson et al.
JOURNAL OF IMMUNOLOGY (2002)
Epitope studies with anti-beta(2)-glycoprotein I antibodies from autoantibody and immunized sources
SW Reddel et al.
JOURNAL OF AUTOIMMUNITY (2000)
Epidemiology of the antiphospholipid antibody syndrome
M Petri
JOURNAL OF AUTOIMMUNITY (2000)
Share Paper
